Drug Checking Technology ChallengeBack to all challenges
Next steps for the finalists
- Pilot Testing Phase: January 2020 to December 2020
- Grand Prize Winner Announced: Spring 2021
Raman-based Drug Analysis System
Spectra Plasmonics has developed a portable technology that can accurately identify added drugs, even at trace levels, and protect users from accidental overdoses. The tool requires minimal training to use and allows operators to detect fentanyl and other additives within minutes, enabling real-time data monitoring for communities to better tackle the crisis.
Alexander Boukin and Ari Forman
Scatr Series One
Alex Boukin and Ari Forman (Ontario) are developing a cutting-edge dual spectrometer that will challenge the standard for overdose prevention. By obtaining and analyzing both Raman and Near-Infrared spectra, the device will provide instant, real-time reporting on the identity and concentration of drug mixtures and their analogues. Utilizing a cloud-based machine learning infrastructure, the Series One will continuously update itself to reflect a constantly increasing sample size and the latest in spectroscopy science. The data will be presented in a user-friendly interface designed for health workers in the field without the need for chemical analysis training.
Dr. Dan Werb and Dr. Drew Hall
A smartphone-based drug checking technology and data dissemination tool
Dan Werb and Drew Hall are developing a smartphone-based portable drug checking technology to detect toxic adulterants in street drugs. The device uses non-destructive electronic interrogation of the sample and then transmits data to an app for analysis that provides users with quantitative information about their drug sample. This information is then aggregated to provide information about trends in the composition of the street drug market. Because the technology employs disposable sensors, it can be continually adjusted to account for the emergence of new adulterants and toxic chemicals in the street drug supply.
|Lead Applicant||Organization||Proposal Title|
|Dr. Dao Hinh Nguyen||Scintrex Trace Corp.||Improvement of GC-SID for the detection of Fentanyl and Fentanyl Analogs|
|Gavin W. Huang||5Bay Healthcare||PANOS Drug Detector|
|Dr. James Wylde||Greenlight Analytical Inc.||Advanced Narcotics Analyzer for Field Applications|
|Dr. Chris Gill||Applied Environmental Research Laboratories – Vancouver Island University||HarmCheck: Rapid, Quantitative Opioid Drug Checking by Paper Spray Mass Spectrometry (PS-MS)|
|Malcolm Eade||Spectra Plasmonics||Raman-based Drug Analysis System|
|Dr. Jean-Francois Masson||Université de Montréal||SERS instrument for counting molecules in injectable drugs|
|Alexander Boukin and Ari Forman||Scatr||Scatr Series One|
|Dr. Dan Werb and Dr. Drew Hall||DoseCheck Technologies||A smartphone-based drug checking technology and data dissemination tool|
|Dr. Jeffrey C. Smith and Dr. Lynne E. Leonard||Department of Chemistry, Carleton University and School of Epidemiology and Public Health, University of Ottawa||Determining Presence and Concentration of Opioids in Drug Samples Using Novel Rapid Non-Invasive Portable Mass Spectrometry Technology|
Who can apply
Open to any for-profit and not-for-profit organizations such as companies, industry associations, Indigenous organizations and research associations, as well as post-secondary institutions.
- Challenge Launch: October 2nd, 2018
- Application Deadline: February 1st, 2019
- First Selection Phase - Semi-Finalists Announced: April 2019
- Incubation Period: April to September 2019
- Second Selection Phase - Finalists Announced: December 2019
- Pilot-Phase: January 2020 to December 2020
- Grand Prize Announced: Spring 2021
- Up to 10 Semi-Finalists will receive an estimated prize of $25,000 to further develop their prototypes.
- Up to 5 Semi-Finalists will receive an estimated prize of $100,000 to pilot their prototypes.
- A grand prize winner will receive an estimated prize of $1,000,000 to further develop and build their product.